nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenobarbital—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.188	0.413	CbGbCtD
Methylphenobarbital—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.188	0.413	CbGbCtD
Methylphenobarbital—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0788	0.174	CbGbCtD
Methylphenobarbital—CHRNA7—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.025	0.0478	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0239	0.0457	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA3—chronic obstructive pulmonary disease	0.0238	0.0456	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.0206	0.0394	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0204	0.0389	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0204	0.0389	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0195	0.0373	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.019	0.0363	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.0168	0.0321	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.0168	0.0321	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0166	0.0317	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0155	0.0296	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.0137	0.0262	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Nicotine Activity on Dopaminergic Neurons—CHRNA5—chronic obstructive pulmonary disease	0.0121	0.0232	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Nicotine Activity on Dopaminergic Neurons—CHRNA3—chronic obstructive pulmonary disease	0.0099	0.0189	CbGpPWpGaD
Methylphenobarbital—Hexobarbital—CYP1A2—chronic obstructive pulmonary disease	0.00481	0.215	CrCbGaD
Methylphenobarbital—GABRA6—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00467	0.00892	CbGpPWpGaD
Methylphenobarbital—GABRA4—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00461	0.00881	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00458	0.00876	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00417	0.00797	CbGpPWpGaD
Methylphenobarbital—GABRA6—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00416	0.00795	CbGpPWpGaD
Methylphenobarbital—GABRA4—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00411	0.00785	CbGpPWpGaD
Methylphenobarbital—GABRA5—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0041	0.00782	CbGpPWpGaD
Methylphenobarbital—GABRA3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00402	0.00768	CbGpPWpGaD
Methylphenobarbital—GABRA2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00395	0.00755	CbGpPWpGaD
Methylphenobarbital—GABRA5—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00365	0.00697	CbGpPWpGaD
Methylphenobarbital—Antipyrine—CYP1A2—chronic obstructive pulmonary disease	0.0036	0.161	CrCbGaD
Methylphenobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00359	0.00686	CbGpPWpGaD
Methylphenobarbital—GABRA3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00358	0.00685	CbGpPWpGaD
Methylphenobarbital—GABRA2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00352	0.00673	CbGpPWpGaD
Methylphenobarbital—GABRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00337	0.00644	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00333	0.00636	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00327	0.00624	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00303	0.00579	CbGpPWpGaD
Methylphenobarbital—GABRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.003	0.00574	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00293	0.00559	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00291	0.00557	CbGpPWpGaD
Methylphenobarbital—Primidone—CYP1A2—chronic obstructive pulmonary disease	0.00278	0.124	CrCbGaD
Methylphenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00275	0.00525	CbGpPWpGaD
Methylphenobarbital—Pethidine—SLC6A4—chronic obstructive pulmonary disease	0.00273	0.122	CrCbGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.0027	0.00516	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00266	0.00509	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00266	0.00509	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00246	0.00469	CbGpPWpGaD
Methylphenobarbital—Fosphenytoin—ALB—chronic obstructive pulmonary disease	0.0024	0.107	CrCbGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00228	0.00436	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00225	0.00431	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00224	0.00428	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.0022	0.00421	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.0022	0.0042	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00217	0.00415	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00212	0.00405	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00212	0.00404	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00207	0.00395	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00206	0.00394	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00201	0.00384	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.002	0.00383	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.002	0.00382	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.002	0.00382	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00197	0.00376	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00193	0.00369	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00191	0.00364	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00188	0.00359	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00186	0.00356	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00184	0.00351	CbGpPWpGaD
Methylphenobarbital—Phenobarbital—CYP1A1—chronic obstructive pulmonary disease	0.00182	0.0814	CrCbGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00182	0.00347	CbGpPWpGaD
Methylphenobarbital—Phenobarbital—CYP1A2—chronic obstructive pulmonary disease	0.00176	0.0785	CrCbGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00172	0.00328	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.0017	0.00324	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00169	0.00322	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00168	0.00321	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00165	0.00315	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00164	0.00313	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.00164	0.00313	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00163	0.00312	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00163	0.00312	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00162	0.0031	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.0016	0.00307	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.0016	0.00306	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.0016	0.00306	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00158	0.00302	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00158	0.00301	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00154	0.00294	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00153	0.00293	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00153	0.00293	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00151	0.00288	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00148	0.00283	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00148	0.00283	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00145	0.00278	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00145	0.00277	CbGpPWpGaD
Methylphenobarbital—Pethidine—ALB—chronic obstructive pulmonary disease	0.00144	0.0642	CrCbGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00143	0.00273	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00143	0.00272	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.0014	0.00267	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.0014	0.00267	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00138	0.00264	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00138	0.00263	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00134	0.00257	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00132	0.00251	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.0013	0.00248	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00129	0.00246	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00127	0.00243	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00127	0.00242	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00126	0.0024	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00125	0.00239	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00125	0.00238	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00124	0.00237	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00124	0.00236	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00123	0.00235	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00123	0.00234	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00121	0.00231	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00121	0.0023	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00119	0.00228	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00119	0.00227	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00118	0.00226	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00117	0.00224	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00115	0.0022	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00113	0.00217	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00111	0.00213	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00111	0.00213	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00107	0.00205	CbGpPWpGaD
Methylphenobarbital—Phenytoin—ALB—chronic obstructive pulmonary disease	0.00106	0.0473	CrCbGaD
Methylphenobarbital—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00106	0.00202	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00106	0.00202	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00105	0.002	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00103	0.00196	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00102	0.00194	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00101	0.00193	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000981	0.00187	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00095	0.00181	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000941	0.0018	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000935	0.00179	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000924	0.00176	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000916	0.00175	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000914	0.00175	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000908	0.00173	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000908	0.00173	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000902	0.00172	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000879	0.00168	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000868	0.00166	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000774	0.00148	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000769	0.00147	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000741	0.00142	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000713	0.00136	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000688	0.00131	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000664	0.00127	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.00066	0.00126	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000656	0.00125	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000635	0.00121	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000627	0.0012	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00062	0.00118	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000562	0.00107	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000561	0.00107	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000559	0.00107	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000539	0.00103	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000538	0.00103	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000521	0.000995	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000514	0.000982	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000479	0.000915	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000474	0.000905	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000468	0.000895	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000455	0.00087	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000435	0.00083	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000429	0.000819	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000399	0.000763	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000394	0.000752	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000394	0.000752	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.00039	0.000746	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000388	0.000742	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000386	0.000738	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000379	0.000723	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000373	0.000713	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000347	0.000663	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000333	0.000636	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000333	0.000636	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000328	0.000627	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000324	0.000619	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000319	0.000609	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000315	0.000602	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000315	0.000601	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000305	0.000582	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000302	0.000577	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000298	0.000569	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000286	0.000547	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000282	0.000539	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000282	0.000539	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00028	0.000534	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000275	0.000525	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00027	0.000516	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000242	0.000462	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	0.00023	0.00044	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00023	0.00044	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000202	0.000385	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	0.000196	0.000375	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000195	0.000373	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000191	0.000366	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000189	0.000361	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000182	0.000349	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000168	0.000321	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000165	0.000315	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000164	0.000314	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000162	0.00031	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000152	0.000291	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000151	0.000289	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	0.000148	0.000283	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000138	0.000264	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000138	0.000263	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.00021	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000107	0.000205	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000106	0.000202	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.67e-05	0.000185	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.91e-05	0.00017	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.1e-05	0.000155	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	8.01e-05	0.000153	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.47e-05	0.000143	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.43e-05	0.000142	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.33e-05	0.00014	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	7.31e-05	0.00014	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.83e-05	0.00013	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.73e-05	0.000129	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.47e-05	0.000124	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.62e-05	0.000107	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.54e-05	0.000106	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.16e-05	9.86e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.89e-05	9.35e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	4.4e-05	8.41e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.21e-05	8.04e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.33e-05	6.35e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.18e-05	6.08e-05	CbGpPWpGaD
